FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Clinical trial NCT06185569 · RECRUITING
Trial details
- NCT number
- NCT06185569
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-15
- Primary completion
- 2028-09-01
- Enrollment
- 4500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.